GRI Bio, Inc. - GRI
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | History | New | 28,784 | 50 | 0.0% | — | 1 | +28,784 | New | Q2 2026 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | History | New | 21,368 | 37 | 0.0% | — | 2 | +21,368 | New | Q2 2026 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Reduced | 13,869 | 24 | 0.0% | 0.0% | 3 | -4,569 | -24.78% | Q2 2026 | Aug 12, 2026 |
| CITADEL ADVISORS LLC | History | New | 13,376 | 23 | 0.0% | — | 4 | +13,376 | New | Q2 2026 | Sep 02, 2026 |
| MORGAN STANLEY | History | New | 8,737 | 15 | 0.0% | — | 5 | +8,737 | New | Q2 2026 | Aug 13, 2026 |
| UBS Group AG | History | Reduced | 4,920 | 8 | 0.0% | 0.0% | 6 | -3,802 | -43.59% | Q2 2026 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | History | Added to | 2,434 | 4 | 0.0% | 0.0% | 7 | +1,374 | 129.62% | Q2 2026 | Aug 11, 2026 |
| BARCLAYS PLC | History | New | 83 | 0 | — | — | — | +83 | New | Q2 2026 | Aug 14, 2026 |
| SBI Securities Co., Ltd. | History | Closed out | 0 | 0 | — | — | — | -4 | -100.0% | Q2 2026 | Jul 22, 2026 |
| Caitong International Asset Management Co., Ltd | History | New | 2 | 0 | — | — | — | +2 | New | Q2 2026 | Aug 04, 2026 |
| DANSKE BANK A/S | History | No change | 2 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 10, 2026 |
| BlackRock, Inc. | History | No change | 7 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 07, 2026 |